In a previous study comparing the efficacy and tolerability of magnesium and sodium salts of valproic acid in 45 patients with various forms of epilepsy, Matera et al. [13] found an overall ...
The long-term safety of TEV-‘749 and incidence of PDSS are also being evaluated in the SOLARIS open-label study (Period 2), with safety data topline readout expected in the first half of 2025.
The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.